최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.26 no.10 = no.198, 2016년, pp.1189 - 1195
전희영 (대덕대학교 뷰티과) , 김환규 (전북대학교 자연과학대학 생명과학과)
Vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) are potent angiogenic factors that have been used clinically to induce angiogenesis. To enable migration and invasion, cells must proliferate and secrete proteinases, which degrade the surrounding extracellular matrix. The ...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Apoorva, S., Edward, A. S., Archana, V. P., Che, B. P., Brown, M., García, A. J. and Davis, M. E. 2012. Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats. PLoS One 7 , e50980.
Badiga, A. V., Chetty, C., Kesanakurti, D., Are, D., Gujrati, M., Klopfenstein, J. D., Dinh, D. H. and Rao, J. S. 2011. MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells. PLoS One 6 , e20614.
Bauvois, B. 2012. New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim. Biophys. Acta . 1825 , 29-36.
Belotti, D., Paganoni, P., Manenti, L., Garofalo, A., Marchini, S., Taraboletti, G. and Giavazzi, R. 2003. Matrix metalloproteinases(MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res . 63 , 5224-5229.
Bonnans, C., Chou, J. and Werb, Z. 2014. Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell. Biol . 15 , 786-801.
Cai, H., Xue, Y., Li, Z., Hu, Y., Wang, Z., Liu, W., Li, Z. and Liu, Y. 2015. Roundabout4 suppresses glioma-induced endothelial cell proliferation, migration and tube formation in vitro by inhibiting VEGR2-mediated PI3K/AKT and FAK signaling pathways. Cell. Physiol. Biochem . 35 , 1689-1705.
Carmeliet, P. 2005. Angiogenesis in life, disease and medicine. Nature 15 , 932-936.
Charlesworth, P. J. and Harris, A. L. 2006. Mechanisms of disease: angiogenesis in urologic malignancies. Nat. Clin. Pract. Urol . 3 , 157-169.
Chen, F. X., Qian, Y. R., Duan, Y. H., Ren, W. W., Yang, Y., Zhang, C. C., Qiu, Y. M. and Ji, Y. H. 2009. Down-regulation of 67LR reduces the migratory activity of human glioma cells in vitro . Brain Res. Bull . 14 , 402-408.
Choe, G., Park, J. K., Jouben-Steele, L., Kremen, T. J., Liau, L. M., Vinters, H. V., Cloughesy, T. F. and Mischel, P. S. 2002. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Clin. Cancer Res . 8 , 2894-2901.
Cimpean, A. M., Seclaman, E., Ceauşu, R., Gaje, P., Feflea, S., Anghel, A., Raica, M. and Ribatti, D. 2009. VEGF-A/HGF induce Prox-1 expression in the chick embryo chorioallantoic membrane lymphatic vasculature. Clin. Exp. Med . 10 , 169-172.
Dzwonek, J., Rylski, M. and Kaczmarek, L. 2004. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett . 567 , 129-135.
Egeblad, M. and Werb, Z. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2 , 161-174.
Ferrara, N. 1999. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int . 56 , 794-814.
Guo, P., Imanishi, Y., Cackowski, F. C., Jarzynka, M. J., Tao, H. Q., Nishikawa, R., Hirose, T., Hu, B. and Cheng, S. Y. 2005. Up-Regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5γ2 correlates with the invasiveness of human glioma. Am. J. Pathol . 166 , 877-890.
Kesanakurti, D., Chetty, C., Maddirela, D. R., Gujrati, M. and Rao, J. S. 2012. Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma. Cell Death Dis . 3 , e445.
Klein, S., Giancotti, F. G., Presta, M., Albelda, S. M., Buck, C. A. and Rifkin, D. B. 1993. Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol. Biol. Cell 4 , 973-982.
Kleiner, D. E. and Stetler-Stevenson, W. G. 1999. Matrix metalloproteinases and metastasis. Cancer Chemother. Pharmacol . 43 , S42-S51.
Kondraganti, S., Mohanam, S., Chintala, S. K., Kin, Y., Jasti, S. L., Nirmala, C., Lakka, S. S., Adachi, Y., Kyritsis, A. P., Ali-Osman, F., Sawaya, R., Fuller, G. N. and Rao, J. S. 2000. Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. Cancer Res . 60 , 6851-6855.
Lakka, S. S., Rajan, M., Gondi, C., Yanamandra, N., Chandrasekar, N., Jasti, S. L., Adachi, Y., Siddique, K., Gujrati, M., Olivero, W., Dinh, D. H., Kouraklis, G., Kyritsis, A. P. and Rao, J. S. 2002. Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene 21 , 8011-8019.
Lu, K. V., Chang, J. P., Parachoniak, C. A., Pandika, M. M., Aghi, M. K., Meyronet, D., Isachenko, N., Fouse, S. D., Phillips, J. J., Cheresh, D. A., Park, M. and Bergers, G. 2012. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell 22 , 21-35.
Min, J. K., Lee, Y. M., Kim, J. H., Kim, Y. M., Kim, S. W., Lee, S. Y., Gho, Y. S., Oh, G. T. and Kwon, Y. G. 2005. Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway. Circ. Res . 18 , 300-307.
Pupa, S. M., Me‘nard, S., Forti, S. and Tagliabue, E. 2002. New insights into the role of extracellular matrix during tumor onset and progression. J. Cell. Physiol . 192 , 259-267.
Roomi, M. W., Monterrey, J. C., Kalinovsky, T., Rath, M. and Niedzwiecki, A. 2010. Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines. Oncol. Rep . 24 , 747-757.
Rosen, E. M., Lamszus, K., Laterra, J., Polverini, P. J., Rubin, J. S. and Goldberg, I. D. 1997. HGF/SF in angiogenesis. Ciba Found Symp . 212 , 215-226.
Roth, D., Piekarek, M., Paulsson, M., Christ, H., Bloch, W., Krieg, T., Davidson, J. M. and Eming, S. A. 2006. Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair. Am. J. Pathol . 168 , 670-684.
Vanmeter, T. E., Rooprai, H. K., Kibble, M. M., Fillmore, H. L., Broaddus, W. C. and Pilkington, G. J. 2001. The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J. Neuro. Oncol . 53 , 213-235.
Wang, G. M., Kovalenko, B., Huang, Y. and Moscatelli, D. 2007. Vascular endothelial growth factor and angiopoietin are required for prostate regeneration. Prostate 67 , 485-499.
Wick, W., Platten, M. and Weller, M. 2001. Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta. J. Neurooncol . 53 , 177-185.
Xin, X., Yang, S., Ingle, G., Zlot, C., Rangell, L., Kowalski, J., Schwall, R., Ferrara, N. and Gerritsen, M. E. 2001. Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo . Am. J. Pathol . 158 , 1111-1120.
Yadav, L., Puri, N., Rastogi, V., Satpute, P. and Sharma, V. 2015. Tumour angiogenesis and angiogenic inhibitors. J. Clin. Diagn. Res . 9 , XE01-XE05.
Zachary, I. 2003. VEGF signalling: integration and multi-tasking in endothelial cell biology. Biochem. Soc. Trans . 31 , 1171-1177.
Zhang, Y. W., Su, Y., Volpert, O. V. and Vande Woude, G. F. 2002. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc. Natl. Acad. Sci. USA 100 , 12718-12723.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.